Inhibikase Therapeutics IKT
NASDAQ IKT
$1.93 -0.13 (-6.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Inhibikase Therapeutics (IKT) Times Interest Earned (2020 - 2022)

Updated

Inhibikase Therapeutics' (IKT) Times Interest Earned came in at -928119.20 for Q1 2022, compared with -222.54 a year earlier.

Analysis

Inhibikase Therapeutics (IKT) Times Interest Earned (2020 - 2022) Analysis & Trends

For FY2021, Inhibikase Therapeutics' Times Interest Earned stood at -741.16.

  • In prior years, Inhibikase Therapeutics' Times Interest Earned was -95.86 in FY2020.
  • The Q1 2022 figure stands as the lowest quarterly Times Interest Earned in data going back to Q1 2020.
  • According to Business Quant data, Times Interest Earned for the three prior quarters was -31907.98 (Q4 2021), -28477.96 (Q3 2021) and -336.50 (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inhibikase Therapeutics 359.62 Mn -225.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -928,119.20
Dec 31, 2021 -31,907.98
Sep 30, 2021 -28,477.96
Jun 30, 2021 -336.50
Mar 31, 2021 -222.54
Dec 31, 2020 -168.21
Sep 30, 2020 -96.33
Jun 30, 2020 -52.08
Mar 31, 2020 -72.73
API Access

Inhibikase Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=IKT&period=max&api_key=YOUR_API_KEY